Monitoraggio anticorpi monoclonali per COVID-19: pubblicato il ventitreesimo report

Eighth AIFA Report on the surveillance of COVID-19 vaccines

Prevention of SARS-CoV-2 (COVID-19) infections: requests for the import of unauthorized medicines used in place of authorized vaccines

AIFA’s Scientific Technical Committee issues opinion on administering additional doses of COVID-19 vaccines

Increase in manufacturing capacity for COVID-19 vaccine from BioNTech/Pfizer

EMA evaluating data on booster dose of COVID-19 vaccine Comirnaty

Monitoraggio anticorpi monoclonali per COVID-19: pubblicato il ventiduesimo report

ECDC and EMA highlight considerations for additional and booster doses of COVID-19 vaccines

Monitoraggio anticorpi monoclonali per COVID-19: pubblicato il ventunesimo report

After serious adverse reactions affecting coagulation with first dose Vaxzevria possible booster with m-RNA vaccine even in over 60s

Increase in vaccine manufacturing capacity for COVID-19 vaccines from BioNTech / Pfizer and Moderna

Monitoraggio anticorpi monoclonali per COVID-19: pubblicato il ventesimo report

AIFA denies fake news: authorisations for anti-COVID vaccines remain valid

EMA starts evaluating use of RoActemra in hospitalised adults with severe COVID-19

Monitoraggio anticorpi monoclonali per COVID-19: pubblicato il diciannovesimo report

Modifiche Registro - anticorpi monoclonali COVID-19

Monitoraggio anticorpi monoclonali per COVID-19: pubblicato il diciottesimo report

Definition of optimal use of anti COVID-19 monoclonal antibodies

ECDC and EMA update on COVID-19

Seventh AIFA Report on the surveillance of COVID-19 vaccines